Evidence map›Paper›PMID 23247843›Full record

ArticleJAMA internal medicine2013

Increasing colorectal cancer screening adherence: comment on "A randomized comparison of print and web communication on colorectal cancer screening".

Audrey H Calderwood, Hemant K Roy

Abstract readComment
In one paragraph

Article in JAMA internal medicine, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Trial
  2. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

2 authors.

Audrey H CalderwoodSection of Gastroenterology, Boston Medical Center and Boston University School of Medicine, Boston, Massachusetts, USA.
Hemant K Roy

Funding

Spectral Markers for Early Detection of Colon NeoplasiaU01CA111257 · NCI · NORTHSHORE UNIV HEALTHSYSTEM RES INST · PI BACKMAN, VADIM, ROY, HEMANT K. · 2004 to 2015
$6.0M
Nanoscale/Molecular analysis of Fecal Colonocytes for Colorectal Cancer ScreeningR01CA165309 · NCI · NORTHWESTERN UNIVERSITY · PI BACKMAN, VADIM, ROY, HEMANT K. · 2012 to 2016
$2.8M
Transforming Colorectal Cancer Screening through Multimodal Spectral MarkersR01CA156186 · NCI · ENDEAVOR HEALTH CLINICAL OPERATIONS · PI BACKMAN, VADIM, ROY, HEMANT K. · 2011 to 2015
$2.8M
Nanocytological Fecal Assessment to Personalize Colonoscopic SurveillanceR42CA168055 · NCI · NANOCYTOMICS, LLC · PI ROY, HEMANT K. · 2012 to 2014
$1.8M
A Novel Colonoscopy Bowel Preparation Scale: Education, Validation, and UtilityK08DK090150 · NIDDK · BOSTON MEDICAL CENTER · PI CALDERWOOD, AUDREY HONG · 2011 to 2015
$711k
NCI NIH HHS R01 CA156186NCI NIH HHS R01 CA156186 02NCI NIH HHS R01 CA165309NCI NIH HHS R42 CA168055NCI NIH HHS R42 CA168055 01NCI NIH HHS U01 CA111257NIDDK NIH HHS K08 DK090150NIDDK NIH HHS K08DK090150
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Mass ScreeningPatient Education as TopicColorectal NeoplasmsFemaleHealth CommunicationHumansPatient Acceptance of Health Care

Identifiers

PMID23247843
PMCPMC3873733

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.